Biovica announced that the company has received a license for Maryland state, the 18th largest state in the US. The license means that Biovica can now perform analysis and report patient samples from all US states, except for New York and Washington DC.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
2.75 SEK | +2.04% |
|
+5.77% | +6.59% |
28/06 | Biovica to Provide Biomarker Testing for US Biopharmaceutical Company | MT |
28/06 | Biovica International Signs New Agreement Supporting Pharma Development | CI |
![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+6.59% | 21.81M | |
-42.89% | 7.8B | |
+6.77% | 3.53B | |
-1.35% | 2.24B | |
-27.06% | 1.84B | |
-21.23% | 1.66B | |
+9.31% | 951M | |
+29.42% | 811M | |
-12.66% | 670M | |
-26.12% | 533M |
- Stock Market
- Equities
- BIOVIC B Stock
- News Biovica International AB
- Biovica Receives License for Maryland State